Mia C. Weiss

MedicineBiochemistry, Genetics and Molecular BiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Interim phase 1 results for SQ3370 in advanced solid tumors.”.

Interim phase 1 results for SQ3370 in advanced solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3085

N/A

0.241DataRank · unranked

4 citations

Kathleen Batty, Maša Alečković, Vivek A. Bhadri, Nam Q. Bui, Alexander Guminski +10 more

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11508

N/A

0DataRank · unranked

9 citations

Angela C. Hirbe, Jingqin Luo, Peter John Oppelt, Mia C. Weiss, Vanessa Eulo +14 more

A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps11578

N/A

0DataRank · unranked

6 citations

Shing Mirn Lee, Mia C. Weiss, Brittany L. Siontis, Benjamin Powers, Warren Chow +6 more

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11531

N/A

0DataRank · unranked

1 citations

Shing M. Lee, Liner Ge, Mihaela Druta, Anthony P. Conley, Mary Louise Keohan +14 more